TNF and COVID-19: It has been reported that TNFα and INFγ can act synergistically to trigger inflammatory cell death in vitro and in vivo, which mimics the SARS-CoV-2-induced cytokine shock syndrome (CSS) that occurs in COVID-19 patients (50).